Search tips
Search criteria 


Logo of jmedgeneJournal of Medical GeneticsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Med Genet. 2005 November; 42(11): 811–819.
PMCID: PMC1735949

Genetics of skin appendage neoplasms and related syndromes


In the past decade the molecular basis of many inherited syndromes has been unravelled. This article reviews the clinical and genetic aspects of inherited syndromes that are characterised by skin appendage neoplasms, including Cowden syndrome, Birt–Hogg–Dube syndrome, naevoid basal cell carcinoma syndrome, generalised basaloid follicular hamartoma syndrome, Bazex syndrome, Brooke–Spiegler syndrome, familial cylindromatosis, multiple familial trichoepitheliomas, and Muir–Torre syndrome.

Full Text

The Full Text of this article is available as a PDF (255K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Fuchs Elaine, Raghavan Srikala. Getting under the skin of epidermal morphogenesis. Nat Rev Genet. 2002 Mar;3(3):199–209. [PubMed]
  • Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet. 2000 Nov;37(11):828–830. [PMC free article] [PubMed]
  • Starink TM, van der Veen JP, Arwert F, de Waal LP, de Lange GG, Gille JJ, Eriksson AW. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet. 1986 Mar;29(3):222–233. [PubMed]
  • Starink TM, Hausman R. The cutaneous pathology of facial lesions in Cowden's disease. J Cutan Pathol. 1984 Oct;11(5):331–337. [PubMed]
  • Pilarski R, Eng C. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet. 2004 May;41(5):323–326. [PMC free article] [PubMed]
  • Brownstein MH, Wolf M, Bikowski JB. Cowden's disease: a cutaneous marker of breast cancer. Cancer. 1978 Jun;41(6):2393–2398. [PubMed]
  • Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M. Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer. Hum Pathol. 1998 Jan;29(1):47–53. [PubMed]
  • Padberg GW, Schot JD, Vielvoye GJ, Bots GT, de Beer FC. Lhermitte-Duclos disease and Cowden disease: a single phakomatosis. Ann Neurol. 1991 May;29(5):517–523. [PubMed]
  • Eng C, Murday V, Seal S, Mohammed S, Hodgson SV, Chaudary MA, Fentiman IS, Ponder BA, Eeles RA. Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J Med Genet. 1994 Jun;31(6):458–461. [PMC free article] [PubMed]
  • Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF, et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet. 1996 May;13(1):114–116. [PubMed]
  • Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997 Apr;15(4):356–362. [PubMed]
  • Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997 May;16(1):64–67. [PubMed]
  • Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997 Mar 28;275(5308):1943–1947. [PubMed]
  • Waite Kristin A, Eng Charis. Protean PTEN: form and function. Am J Hum Genet. 2002 Apr;70(4):829–844. [PubMed]
  • Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, Liaw D, Caron S, Duboué B, Lin AY, et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet. 1998 Mar;7(3):507–515. [PubMed]
  • Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, Bodurtha J, Crowe C, Curtis MA, Dasouki M, et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet. 1999 Aug;8(8):1461–1472. [PubMed]
  • Celebi JT, Tsou HC, Chen FF, Zhang H, Ping XL, Lebwohl MG, Kezis J, Peacocke M. Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTEN. J Med Genet. 1999 May;36(5):360–364. [PMC free article] [PubMed]
  • Zhou X, Hampel H, Thiele H, Gorlin RJ, Hennekam RC, Parisi M, Winter RM, Eng C. Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet. 2001 Jul 21;358(9277):210–211. [PubMed]
  • Birt AR, Hogg GR, Dubé WJ. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol. 1977 Dec;113(12):1674–1677. [PubMed]
  • Pinkus H, Coskey R, Burgess GH. Trichodiscoma. A benign tumor related to haarscheibe (hair disk). J Invest Dermatol. 1974 Aug;63(2):212–218. [PubMed]
  • Collins Gary L, Somach Stephen, Morgan Michael B. Histomorphologic and immunophenotypic analysis of fibrofolliculomas and trichodiscomas in Birt-Hogg-Dube syndrome and sporadic disease. J Cutan Pathol. 2002 Oct;29(9):529–533. [PubMed]
  • De la Torre C, Ocampo C, Doval IG, Losada A, Cruces MJ. Acrochordons are not a component of the Birt-Hogg-Dubé syndrome: does this syndrome exist? Case reports and review of the literature. Am J Dermatopathol. 1999 Aug;21(4):369–374. [PubMed]
  • Roth JS, Rabinowitz AD, Benson M, Grossman ME. Bilateral renal cell carcinoma in the Birt-Hogg-Dubé syndrome. J Am Acad Dermatol. 1993 Dec;29(6):1055–1056. [PubMed]
  • Zbar Berton, Alvord W Gregory, Glenn Gladys, Turner Maria, Pavlovich Christian P, Schmidt Laura, Walther McClellan, Choyke Peter, Weirich Gregor, Hewitt Stephen M, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):393–400. [PubMed]
  • Chung JY, Ramos-Caro FA, Beers B, Ford MJ, Flowers F. Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube syndrome. Int J Dermatol. 1996 May;35(5):365–367. [PubMed]
  • Liu V, Kwan T, Page EH. Parotid oncocytoma in the Birt-Hogg-Dubé syndrome. J Am Acad Dermatol. 2000 Dec;43(6):1120–1122. [PubMed]
  • Vincent Analisa, Farley Mary, Chan Edward, James William D. Birt-Hogg-Dubé syndrome: two patients with neural tissue tumors. J Am Acad Dermatol. 2003 Oct;49(4):717–719. [PubMed]
  • Toro JR, Glenn G, Duray P, Darling T, Weirich G, Zbar B, Linehan M, Turner ML. Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia. Arch Dermatol. 1999 Oct;135(10):1195–1202. [PubMed]
  • Khoo SK, Giraud S, Kahnoski K, Chen J, Motorna O, Nickolov R, Binet O, Lambert D, Friedel J, Lévy R, et al. Clinical and genetic studies of Birt-Hogg-Dubé syndrome. J Med Genet. 2002 Dec;39(12):906–912. [PMC free article] [PubMed]
  • Kahnoski K, Khoo SK, Nassif NT, Chen J, Lobo GP, Segelov E, Teh BT. Alterations of the Birt-Hogg-Dubé gene (BHD) in sporadic colorectal tumours. J Med Genet. 2003 Jul;40(7):511–515. [PMC free article] [PubMed]
  • Shin J-H, Shin Y-K, Ku J-L, Jeong S-Y, Hong S-H, Park S-Y, Kim W-H, Park J-G. Mutations of the Birt-Hogg-Dubé (BHD) gene in sporadic colorectal carcinomas and colorectal carcinoma cell lines with microsatellite instability. J Med Genet. 2003 May;40(5):364–367. [PMC free article] [PubMed]
  • Khoo SK, Bradley M, Wong FK, Hedblad MA, Nordenskjöld M, Teh BT. Birt-Hogg-Dubé syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2. Oncogene. 2001 Aug 23;20(37):5239–5242. [PubMed]
  • Schmidt LS, Warren MB, Nickerson ML, Weirich G, Matrosova V, Toro JR, Turner ML, Duray P, Merino M, Hewitt S, et al. Birt-Hogg-Dubé syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am J Hum Genet. 2001 Oct;69(4):876–882. [PubMed]
  • Nickerson Michael L, Warren Michelle B, Toro Jorge R, Matrosova Vera, Glenn Gladys, Turner Maria L, Duray Paul, Merino Maria, Choyke Peter, Pavlovich Christian P, et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell. 2002 Aug;2(2):157–164. [PubMed]
  • GORLIN RJ, GOLTZ RW. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med. 1960 May 5;262:908–912. [PubMed]
  • Gorlin RJ. Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore) 1987 Mar;66(2):98–113. [PubMed]
  • Bale AE, Yu KP. The hedgehog pathway and basal cell carcinomas. Hum Mol Genet. 2001 Apr;10(7):757–762. [PubMed]
  • Southwick GJ, Schwartz RA. The basal cell nevus syndrome: disasters occurring among a series of 36 patients. Cancer. 1979 Dec;44(6):2294–2305. [PubMed]
  • Murphy KJ. Metastatic basal cell carcinoma with squamous appearances in the naevoid basal cell carcinoma syndrome. Br J Plast Surg. 1975 Oct;28(4):331–334. [PubMed]
  • Winkler PA, Guyuron B. Multiple metastases from basal cell naevus syndrome. Br J Plast Surg. 1987 Sep;40(5):528–531. [PubMed]
  • Taylor WB, Wilkins JW., Jr Nevoid basal cell carcinoma of the palm. Arch Dermatol. 1970 Dec;102(6):654–655. [PubMed]
  • Leppard BJ. Skin cysts in the basal cell naevus syndrome. Clin Exp Dermatol. 1983 Nov;8(6):603–612. [PubMed]
  • Amlashi Seyed F A, Riffaud Laurent, Brassier Gilles, Morandi Xavier. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature. Cancer. 2003 Aug 1;98(3):618–624. [PubMed]
  • Farndon PA, Del Mastro RG, Evans DG, Kilpatrick MW. Location of gene for Gorlin syndrome. Lancet. 1992 Mar 7;339(8793):581–582. [PubMed]
  • Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH, Jr, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 1996 Jun 14;272(5268):1668–1671. [PubMed]
  • Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. 1996 Jun 14;85(6):841–851. [PubMed]
  • Cohen M Michael., Jr The hedgehog signaling network. Am J Med Genet A. 2003 Nov 15;123A(1):5–28. [PubMed]
  • Wicking C, Shanley S, Smyth I, Gillies S, Negus K, Graham S, Suthers G, Haites N, Edwards M, Wainwright B, et al. Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am J Hum Genet. 1997 Jan;60(1):21–26. [PubMed]
  • Brown AC, Crounse RG, Winkelmann RK. Generalized hair-follicle hamartoma, associated with alopecia, aminoacidura, and myasthenia gravis. Arch Dermatol. 1969 Apr;99(4):478–493. [PubMed]
  • Wheeler CE, Jr, Carroll MA, Groben PA, Briggaman RA, Prose NS, Davis DA. Autosomal dominantly inherited generalized basaloid follicular hamartoma syndrome: report of a new disease in a North Carolina family. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):189–206. [PubMed]
  • Akasaka T, Kon S, Mihm MC., Jr Multiple basaloid cell hamartoma with alopecia and autoimmune disease (systemic lupus erythematosus). J Dermatol. 1996 Nov;23(11):821–824. [PubMed]
  • Morton S, Stevens A, Powell RJ. Basaloid follicular hamartoma, total body hair loss and SLE. Lupus. 1998;7(3):207–209. [PubMed]
  • Jih Debra M, Shapiro Michael, James William D, Levin Marc, Gelfand Joel, Williams Patrick T, Oakey Rebecca J, Fakharzadeh Steven, Seykora John T. Familial basaloid follicular hamartoma: lesional characterization and review of the literature. Am J Dermatopathol. 2003 Apr;25(2):130–137. [PubMed]
  • Ricks M, Elston DM, Sartori CR. Multiple basaloid follicular hamartomas associated with acrochordons, seborrhoeic keratoses and chondrosarcoma. Br J Dermatol. 2002 Jun;146(6):1068–1070. [PubMed]
  • Grachtchouk Vladimir, Grachtchouk Marina, Lowe Lori, Johnson Tim, Wei Lebing, Wang Aiqin, de Sauvage Fred, Dlugosz Andrzej A. The magnitude of hedgehog signaling activity defines skin tumor phenotype. EMBO J. 2003 Jun 2;22(11):2741–2751. [PubMed]
  • Glaessl A, Hohenlautner U, Landthaler M, Vogt T. Sporadic Bazex-Dupré-Christol-like syndrome: early onset basal cell carcinoma, hypohidrosis, hypotrichosis, and prominent milia. Dermatol Surg. 2000 Feb;26(2):152–154. [PubMed]
  • Vabres P, Lacombe D, Rabinowitz LG, Aubert G, Anderson CE, Taieb A, Bonafé JL, Hors-Cayla MC. The gene for Bazex-Dupré-Christol syndrome maps to chromosome Xq. J Invest Dermatol. 1995 Jul;105(1):87–91. [PubMed]
  • Welch JP, Wells RS, Kerr CB. Ancell-Spiegler cylindromas (turban tumours) and Brooke-Fordyce Trichoepitheliomas: evidence for a single genetic entity. J Med Genet. 1968 Mar;5(1):29–35. [PMC free article] [PubMed]
  • Gottschalk HR. Proceedings: Dermal eccrine cylindroma, epithelioma adenoides cysticum of Brooke, and ecrine spiradenoma. Arch Dermatol. 1974 Sep;110(3):473–474. [PubMed]
  • Carsuzaa F, Carloz E, Lebeuf M, Grob JJ, Arnoux D. Trichoépithéliomes multiples, cylindromes, grains de milium, dégénérescence carcinomateuse. Ann Dermatol Venereol. 1992;119(10):746–748. [PubMed]
  • Uede Koji, Yamamoto Yuki, Furukawa Fukumi. Brooke-Spiegler syndrome associated with cylindroma, trichoepithelioma, spiradenoma, and syringoma. J Dermatol. 2004 Jan;31(1):32–38. [PubMed]
  • Gerretsen AL, van der Putte SC, Deenstra W, van Vloten WA. Cutaneous cylindroma with malignant transformation. Cancer. 1993 Sep 1;72(5):1618–1623. [PubMed]
  • Ayhan M, Adanali G, Senen D, Gorgu M, Erdogan B. Rarely seen cutaneous lesions in an elderly patient: malignant transformation of multiple trichoepithelioma. Ann Plast Surg. 2001 Jul;47(1):98–99. [PubMed]
  • Lo JS, Snow SN, Reizner GT, Mohs FE, Larson PO, Hruza GJ. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol. 1991 May;24(5 Pt 1):715–719. [PubMed]
  • Ishikawa M, Nakanishi Y, Yamazaki N, Yamamoto A. Malignant eccrine spiradenoma: a case report and review of the literature. Dermatol Surg. 2001 Jan;27(1):67–70. [PubMed]
  • Jungehülsing M, Wagner M, Damm M. Turban tumour with involvement of the parotid gland. J Laryngol Otol. 1999 Aug;113(8):779–783. [PubMed]
  • Biggs PJ, Wooster R, Ford D, Chapman P, Mangion J, Quirk Y, Easton DF, Burn J, Stratton MR. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene. Nat Genet. 1995 Dec;11(4):441–443. [PubMed]
  • Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, Green H, Brown C, Biggs PJ, Lakhani SR, et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet. 2000 Jun;25(2):160–165. [PubMed]
  • Hu Guofang, Onder Meltem, Gill Melissa, Aksakal Burhan, Oztas Murat, Gürer M Ali, Celebi Jülide Tok. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome. J Invest Dermatol. 2003 Oct;121(4):732–734. [PubMed]
  • Gerretsen AL, Beemer FA, Deenstra W, Hennekam FA, van Vloten WA. Familial cutaneous cylindromas: investigations in five generations of a family. J Am Acad Dermatol. 1995 Aug;33(2 Pt 1):199–206. [PubMed]
  • Poblete Gutiérrez Pamela, Eggermann Thomas, Höller Daniela, Jugert Frank K, Beermann Torsten, Grussendorf-Conen Elke-Ingrid, Zerres Klaus, Merk Hans F, Frank Jorge. Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. J Invest Dermatol. 2002 Aug;119(2):527–531. [PubMed]
  • Brummelkamp Thijn R, Nijman Sebastian M B, Dirac Annette M G, Bernards René Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature. 2003 Aug 14;424(6950):797–801. [PubMed]
  • Regamey Alexandre, Hohl Daniel, Liu Jia Wei, Roger Thierry, Kogerman Priit, Toftgard Rune, Huber Marcel. The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor. J Exp Med. 2003 Dec 15;198(12):1959–1964. [PMC free article] [PubMed]
  • Trompouki Eirini, Hatzivassiliou Eudoxia, Tsichritzis Theodore, Farmer Hannah, Ashworth Alan, Mosialos George. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature. 2003 Aug 14;424(6950):793–796. [PubMed]
  • Schmidt-Ullrich R, Aebischer T, Hülsken J, Birchmeier W, Klemm U, Scheidereit C. Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices. Development. 2001 Oct;128(19):3843–3853. [PubMed]
  • Seitz CS, Deng H, Hinata K, Lin Q, Khavari PA. Nuclear factor kappaB subunits induce epithelial cell growth arrest. Cancer Res. 2000 Aug 1;60(15):4085–4092. [PubMed]
  • Dajee Maya, Lazarov Mirella, Zhang Jennifer Y, Cai Ti, Green Cheryl L, Russell Alan J, Marinkovich M Peter, Tao Shiying, Lin Qun, Kubo Yoshiaki, et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature. 2003 Feb 6;421(6923):639–643. [PubMed]
  • Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg. 1967 Mar;54(3):191–195. [PubMed]
  • Torre D. Multiple sebaceous tumors. Arch Dermatol. 1968 Nov;98(5):549–551. [PubMed]
  • Bitran J, Pellettiere EV. Multiple sebaceous gland tumors and internal carcinoma: Torre's syndrome. Cancer. 1974 Mar;33(3):835–836. [PubMed]
  • Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995 Jul;33(1):90–104. [PubMed]
  • Harwood CA, Swale VJ, Bataille VA, Quinn AG, Ghali L, Patel SV, Dove-Edwin I, Cerio R, McGregor JM. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol. 2001 Feb;116(2):246–253. [PubMed]
  • Bordea C, Wojnarowska F, Millard PR, Doll H, Welsh K, Morris PJ. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation. 2004 Feb 27;77(4):574–579. [PubMed]
  • Lynch HT, Fusaro RM, Roberts L, Voorhees GJ, Lynch JF. Muir-Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome. Br J Dermatol. 1985 Sep;113(3):295–301. [PubMed]
  • Kruse R, Rütten A, Lamberti C, Hosseiny-Malayeri HR, Wang Y, Ruelfs C, Jungck M, Mathiak M, Ruzicka T, Hartschuh W, et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998 Jul;63(1):63–70. [PubMed]
  • Bapat B, Xia L, Madlensky L, Mitri A, Tonin P, Narod SA, Gallinger S. The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet. 1996 Sep;59(3):736–739. [PubMed]
  • Kolodner RD, Hall NR, Lipford J, Kane MF, Rao MR, Morrison P, Wirth L, Finan PJ, Burn J, Chapman P. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics. 1994 Dec;24(3):516–526. [PubMed]
  • Narayan Satya, Roy Deodutta. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer. 2003 Dec 12;2:41–41. [PMC free article] [PubMed]
  • Entius MM, Keller JJ, Drillenburg P, Kuypers KC, Giardiello FM, Offerhaus GJ. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res. 2000 May;6(5):1784–1789. [PubMed]
  • Wei Kaichun, Kucherlapati Raju, Edelmann Winfried. Mouse models for human DNA mismatch-repair gene defects. Trends Mol Med. 2002 Jul;8(7):346–353. [PubMed]
  • Kruse Roland, Ruzicka Thomas. DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention. Trends Mol Med. 2004 Mar;10(3):136–141. [PubMed]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group